spacer
home > epc > spring 2009 > the laws of attraction
PUBLICATIONS
European Pharmaceutical Contractor

The Laws of Attraction

The most challenging bottleneck for nearly every clinical trial is the recruitment of the intended number of patients within the planned timeframe. The selection of the best study sites is therefore of crucial importance to the success of a clinical trial. In order to find a suitable site, it is necessary to understand the motivation to participate. These motivations can include:

  • Scientific interest in a new therapy option: this is a very frequent reason to participate in clinical trials, especially for university hospitals and other scientific oriented organisations
  • The possibility to offer clinical studies to the patients: centres for specific indications and severe diseases are expected to be able to provide the option to participate in clinical trials to their patients
  • Strong relation to the sponsor: if an investigator has already been involved in early stages of the clinical development, they are certainly likely to be interested in participating in later phase clinical studies
  • Financial interests: especially for clinical studies with substances that are not in the frontline of scientific interest, the fee for the treatment of patients within a study may be a motivator for participation in a clinical trial

Good sites combine as many of the above-mentioned motivations as possible.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Michael Sigmund is Managing Director of SSS International Clinical Research, which provides CRO services to the pharmaceutical and biotech industry. Michael has about 20 years’ experience in the field of clinical research. After studying veterinary medicine, he received his DVM in 1988 from the University of Munich. He then joined the pharmaceutical industry and held several positions within biotech and contract research companies. Michael has ample experience in setting up and running clinical trials in European countries. His main interest lies in steamlining information concerning clinical trials to allow easy and effective access to relevant status information for all  parties involved. Michael helped to develop SSS’s professional web-based study information system (SIS).

spacer
Michael Sigmund
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Cleaning Validation: What do you need to consider to ensure a successful outcome?

RSSL

Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination. The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support. The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues. So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement